Abstract
Non-contrast-enhanced magnetic resonance angiography has gained renewed interest since the discovery of the association between gadolinium-based contrast agents and nephrogenic systemic fibrosis. The following article is an overview of the different magnetic resonance angiography sequences, the technical possibilities and new developments. Clinical options and recent advancements will be highlighted, and recommendations for non-contrast-enhanced magnetic resonance angiography techniques in different anatomical regions will be given. Furthermore, the authors seek to predict the future of non-contrast-enhanced magnetic resonance angiography, with special focus on patients at risk.
Financial & competing interests disclosure
AD Blankholm works part time as an application specialist for Philips Healthcare. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.